Dec 11, 2023 / 08:00PM GMT
Presentations at ASH
Dec 11, 2023 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Pablo J. Cagnoni
Incyte Corporation - President and Head of Research & Development
* Patrick Mayes
Incyte Corporation - VP of Biotherapeutic Research
* Peter Langmuir
=====================
Conference Call Participants
=====================
* Conor Thomas MacKay
BMO Capital Markets Equity Research - Research Associate
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Eva Xia Privitera
TD Cowen, Research Division - Associate
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst
* Leonid Timashev
RBC Capital Markets, Research Division - Biotechnology Analyst
* Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst &
Incyte Corp
(MEX:INCY)
MXN
1486
0 (0%)
Market Cap: 299.60 Bil
Enterprise Value: 264.63 Bil
PE Ratio: 541.07
PB Ratio: 4.61
GF Score: 80/100 Incyte Corp to Discuss the Key Data Presentations at ASH Transcript
Dec 11, 2023 / 08:00PM GMT
Release Date Price:
MXN1629
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot